^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

PDGFRB (Platelet Derived Growth Factor Receptor Beta)

i
Other names: PDGFRB, Platelet Derived Growth Factor Receptor Beta, Platelet-Derived Growth Factor Receptor, Beta Polypeptide, Beta-Type Platelet-Derived Growth Factor Receptor, Platelet-Derived Growth Factor Receptor Beta, Platelet-Derived Growth Factor Receptor 1, CD140 Antigen-Like Family Member B, PDGF-R-Beta, PDGFR-Beta, PDGFR-1, PDGFR1,Beta Platelet-Derived Growth Factor Receptor, Activated Tyrosine Kinase PDGFRB, CD140b Antigen, NDEL1-PDGFRB , CD140B, IBGC4, JTK12, PENTT, IMF1 , KOGS
13d
Shared molecular features and candidate pathways underlying gastric cancer-depression comorbidity: a systems biology analysis. (PubMed, Front Bioinform)
Critical pathways, encompassing the PI3K-Akt, AGE-RAGE, and proteoglycans pathways, may contribute to the interconnection between GC and depression. These findings illuminate potential molecular linkages between GC and depression, though additional investigation is required to elucidate the underlying mechanisms.
Journal
|
PDGFRB (Platelet Derived Growth Factor Receptor Beta) • NOTCH3 (Notch Receptor 3) • MIR21 (MicroRNA 21) • MIR34A (MicroRNA 34a-5p) • SERPINE1 (Serpin Family E Member 1) • MIR16 (MicroRNA 16) • COL4A1 (Collagen Type IV Alpha 1 Chain) • MIR145 (MicroRNA 145)
14d
Integrative Network Toxicology and Machine Learning Identify AKR1C3 as a Candidate Functional Target of Cypermethrin in Colorectal Cancer. (PubMed, Chem Biol Interact)
Together, these findings identify AKR1C3 as a candidate functional target of cypermethrin and suggest that AKR1C3 may be involved, at least in part, in cypermethrin-induced CRC-relevant cellular injury and oxidative stress. This study provides an exploratory framework for identifying exposure-related molecular targets linking foodborne pesticide residues to CRC-associated biological alterations.
Journal
|
PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • PDGFRA (Platelet Derived Growth Factor Receptor Alpha) • PDGFRB (Platelet Derived Growth Factor Receptor Beta) • AKR1C3 (Aldo-Keto Reductase Family 1 Member C3) • CDC42 (Cell Division Cycle 42) • CYP2C9 (Cytochrome P450 Family 2 Subfamily C Member 9)
15d
Identification of BRCA2 Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung Adenocarcinomas. (PubMed, Oncol Res)
To determine whether a similar BRCA2 variant was present in other lung cancer patients, 123 LUAD cases were analyzed, and one (0.81%) possessing a truncating BRCA2 variant (p.Q1429FfsTer20) without any typical driver mutations was identified. BRCA2 GPVs may represent putative pathogenic mutations, and thus be potential molecular targets for future treatment of LUAD.
Journal • BRCA Biomarker
|
TP53 (Tumor protein P53) • BRCA2 (Breast cancer 2, early onset) • AR (Androgen receptor) • NRG1 (Neuregulin 1) • PDGFRB (Platelet Derived Growth Factor Receptor Beta) • KMT2D (Lysine Methyltransferase 2D) • PIK3R1 (Phosphoinositide-3-Kinase Regulatory Subunit 1) • CARD11 (Caspase Recruitment Domain Family Member 11)
16d
Whole-transcriptome sequencing reveals hypoxic esophageal squamous cell carcinoma-derived migrasomes driving cancer-associated fibroblast activation. (PubMed, Brief Funct Genomics)
Fibroblasts internalized migrasomes and acquired a CAF-like phenotype, showing enhanced migration, elevated secretion of IL-1β/TGF-β, and increased CAF marker expression (α-SMA, COL1A1, COL3A1, FAP, PDGFRβ), with effects most pronounced under hypoxic migrasome treatment. This study characterized hypoxic migrasome whole transcriptome landscapes and suggested that hypoxic migrasomes may promote CAF-like changes in vitro, uncovering a novel ESCC-tumor microenvironment interaction mechanism and offering new perspectives for ESCC research.
Journal
|
PDGFRB (Platelet Derived Growth Factor Receptor Beta) • HIF1A (Hypoxia inducible factor 1, alpha subunit) • TGFB1 (Transforming Growth Factor Beta 1) • COL1A1 (Collagen Type I Alpha 1 Chain) • COL3A1 (Collagen Type III Alpha 1 Chain) • IL1B (Interleukin 1, beta)
16d
Screening and Functional Study of Biomarkers Related to Cell-in-cell Structure in Stomach Adenocarcinoma. (PubMed, Curr Gene Ther)
The five biomarkers provide valuable insights for the early screening, diagnosis, and treatment of STAD.
Journal
|
PDGFRB (Platelet Derived Growth Factor Receptor Beta) • FCGR3A (Fc Fragment Of IgG Receptor IIIa) • COL8A1 (Collagen Type VIII Alpha 1 Chain)
17d
Exploring the molecular mechanism of Coptis-cinnamon in combating gastric cancer via the MAPK Pathway based on network pharmacology. (PubMed, Front Oncol)
Rescue experiments demonstrated that U0126 phenocopied HL-RG effects, while EGF significantly reversed HL-RG-induced functional changes and p-ERK reduction, confirming that HL-RG acts through the MAPK/ERK pathway. HL-RG exerts anti-GC effects by targeting the MAPK pathway and its hub genes, providing a scientific basis for its clinical application.
Journal
|
EGFR (Epidermal growth factor receptor) • PDGFRB (Platelet Derived Growth Factor Receptor Beta) • MMP2 (Matrix metallopeptidase 2) • MMP9 (Matrix metallopeptidase 9)
17d
[68Ga]Ga-NOTA-ATH001 positron emission tomography as a general tool for non-invasive detection of platelet derived growth factor receptor beta in mesenchymal cells. (PubMed, Nucl Med Biol)
[68Ga]Ga-NOTA-ATH001 is a novel, high affinity PDGFRβ-targeting PET tracer that enables in vivo PET imaging of mesenchymal cells in health and disease. Although it does not outperform its DOTA-conjugated analogue, the NOTA chelator offers practical advantages, such as convenient Al18F or 64Cu radiolabeling.
Journal
|
PDGFRB (Platelet Derived Growth Factor Receptor Beta)
19d
Antitumor and resensitizing effects of wogonin in thyroid cancer via PDGFRB-dependent mechanisms. (PubMed, Phytomedicine)
Wogonin exerts remarkable antitumor effects against TC by binding to PDGFRB, leading to its downregulation, and subsequently suppressing the PI3K/AKT pathway. Furthermore, PDGFRB upregulation contributes to lenvatinib resistance in TC, while wogonin partially reverses this resistance in a PDGFRB-dependent manner.
Journal
|
PDGFRB (Platelet Derived Growth Factor Receptor Beta)
|
Lenvima (lenvatinib)
20d
Thyroid Myofibroma in a Child With Turner Syndrome: Integrated Cytologic, Histopathologic, and Molecular Characterization. (PubMed, Pediatr Dev Pathol)
Awareness of this entity is critical to avoid misclassification as other spindle-cell thyroid lesions on FNA. Integrated cytomorphology, immunophenotyping, and PDGFRB-focused molecular analysis provide a robust diagnostic approach and may offer insight into shared pathogenetic mechanisms linking TS and myofibroblastic proliferations.
Journal
|
PDGFRB (Platelet Derived Growth Factor Receptor Beta)
22d
Cephaeline attenuates malignant biological behaviors of colorectal cancer by regulating the Ras signaling pathway (PubMed, Nan Fang Yi Ke Da Xue Xue Bao)
Cephaeline suppresses malignant biological behaviors of CRC possibly by regulating the RAS signaling pathway.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • PDGFRB (Platelet Derived Growth Factor Receptor Beta) • CDH1 (Cadherin 1) • MAPK1 (Mitogen-activated protein kinase 1) • BAX (BCL2-associated X protein) • VEGFC (Vascular Endothelial Growth Factor C) • VIM (Vimentin) • CDH2 (Cadherin 2) • MMP9 (Matrix metallopeptidase 9) • PCNA (Proliferating cell nuclear antigen)
28d
Spatial multi-omics reveals a cancer-associated fibroblast-T cell niche sustaining tissue-resident immunity in clear-cell renal cell carcinoma. (PubMed, Transl Androl Urol)
These results demonstrate that the prognosis of ccRCC is determined by the spatial organization of the immune-stromal cell niche rather than just by the number of immune cells present. The iCAF-CD4 Trm axes may provide opportunities for precision immunomodulatory therapy.
Journal
|
CD8 (cluster of differentiation 8) • PDGFRB (Platelet Derived Growth Factor Receptor Beta) • CD4 (CD4 Molecule)